|
|
|
Volumn 38, Issue 4, 2004, Pages 36-37
|
|
Drug maker to pay $430 million in fines, civil damages.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ACETIC ACID DERIVATIVE;
AMINE;
ANTICONVULSIVE AGENT;
CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;
GABAPENTIN;
ARTICLE;
DRUG INDUSTRY;
DRUG LABELING;
ECONOMICS;
FORGERY;
LEGAL ASPECT;
MARKETING;
STANDARD;
ACETIC ACIDS;
AMINES;
ANTICONVULSANTS;
CYCLOHEXANECARBOXYLIC ACIDS;
DRUG INDUSTRY;
DRUG LABELING;
FRAUD;
GAMMA-AMINOBUTYRIC ACID;
MARKETING;
|
|
EID: 4644252612
PISSN: 03621332
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|